SHS Invests in Develco Pharma

SHS Capital and LPs Invest ~€10M in Develco Pharma

October 7, 2024

Pharmaceuticals

SHS Capital, together with its limited partners and other existing shareholders, is investing approximately €10 million in Develco Pharma to expand manufacturing capacity and accelerate product development in response to exceptionally strong demand. Develco, a specialty pharma developer and manufacturer of modified-release formulations headquartered in Pratteln (DACH region), has been backed by SHS since 2020 and reports an order book exceeding 12 months of revenue.

SHS Acquires 24.9% Minority Stake in Blazejewski MEDI-TECH GmbH

February 27, 2020

Medical Devices

Tuebingen-based investor SHS Gesellschaft fuer Beteiligungsmanagement mbH has taken a 24.9% minority stake in Sexau-based endoscope manufacturer Blazejewski MEDI-TECH GmbH. The investment is intended to provide growth capital, sector expertise and regulatory support to accelerate internationalization and product development (including 3D endoscopy) for the 70-employee medical device firm.

SHS Capital Acquires Majority Stake in Medizintechnik Rostock (MTR)

November 26, 2024

Medical Devices

Tübingen-based private equity firm SHS Capital has acquired a majority stake in German home care provider Medizintechnik Rostock GmbH (MTR) from the company’s two shareholder-managing directors, who remain significant shareholders. The investment will support MTR’s continued growth and nationwide expansion of its rental-based medical device and in-home service offerings across movement, electro and compression therapy.

SHS Capital and ING Corporate Investments Acquire Majority Stake in CAM Bioceramics

July 7, 2023

Medical Devices

German healthcare specialist investor SHS Capital, together with ING Corporate Investments and several co-investors, acquired a majority stake in CAM Bioceramics B.V., a Leiden-based contract development and manufacturing organization (CDMO) for orthobiologic calcium phosphate solutions. Existing owners rolled over a significant stake and management remains in place; the transaction aims to strengthen the business and accelerate investment in people, capabilities and customer partnerships to drive growth.

EQT Acquires Minority Stake in SHL Medical

January 3, 2020

Medical Devices

EQT VIII (EQT) has agreed to acquire a minority stake in SHL Medical, a Switzerland-headquartered manufacturer of advanced drug delivery devices including autoinjectors. The investment will support SHL's next phase of growth, innovation and digitization while leveraging EQT's healthcare expertise; the deal is subject to customary regulatory approvals.

SHS Invests in Blue Ocean Spine GmbH

January 12, 2021

Medical Devices

SHS Gesellschaft für Beteiligungsmanagement (SHS) is the lead investor in Blue Ocean Spine GmbH, a Tuttlingen, Germany-based developer of functional spinal implants that uses additive manufacturing. The investment will support product development, manufacturing scale-up and regulatory activities as Blue Ocean Spine advances next-generation expandable and anchor-equipped cage implants and targets future U.S. FDA approval.